Shares of pSivida Corp. (NASDAQ:PSDV) traded up 3.8% during mid-day trading on Monday . The stock traded as high as $4.15 and last traded at $4.08, with a volume of 203,453 shares changing hands. The stock had previously closed at $3.93.

Separately, FBR & Co reiterated a “buy” rating on shares of pSivida Corp. in a research note on Wednesday, August 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $7.00.

The company’s market cap is $139.42 million. The stock’s 50 day moving average is $3.53 and its 200 day moving average is $3.13.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.